Ming Poi
0000-0001-6065-8662
1 paper found
Refreshing results…
A phase 1 trial of the histone deacetylase inhibitor AR-42 in patients with neurofibromatosis type 2-associated tumors and advanced solid malignancies
Missing publications? Search for publications with a matching author name.